Buy now for a near-term bounce/swing: price is sitting just above key support (S1 ~6.582) with RSI near oversold, which favors a quick rebound setup.
Options sentiment is bullish (low put/call ratios), supporting a risk-on bias despite the weak tape.
Upside is likely capped near resistance (R1 ~6.719, R2 ~6.762) and the Street PT (UBS $6.50) is already below the current price—so this is more of a tactical buy than a “re-rate higher” story.
Volatility: 30D IV ~29.67 vs historical vol ~16.89 → options are priced rich, consistent with elevated uncertainty.
IV context: IV percentile ~79.28 (high vs recent distribution), while IV rank ~14.95 (not extreme vs yearly range) → volatility is elevated recently, but not at the most extreme annual levels.
Liquidity/Activity: today’s volume 36 vs 5D/10D avg (51/76.6) → not a crowded options day, but call OI (2106) > put OI (879) supports a bullish tilt.
Technical Summary
Sell
5
Buy
7
Positive Catalysts
growth** in revenue, net income, and EPS suggests operating momentum vs prior year.
Neutral/Negative Catalysts
which can limit incremental upside from “PT-chasing” buyers.
Gross Margin: 98.04%, +3.12% YoY (margin profile remains extremely high and improved).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent action (2025-11-19): UBS (Doug Harter) raised PT to $6.50 from $6.25 and maintained Buy.
Trend: the latest update is a positive revision (PT raise) with a continued Buy stance.
Wall Street pro view (pros): improved target and Buy rating imply confidence in fundamentals/earnings power.
Wall Street con view (cons): PT below current price suggests the Street may view the stock as near fair value in the near term, limiting upside enthusiasm right now.
Wall Street analysts forecast HRZN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HRZN is 6.67 USD with a low forecast of 6 USD and a high forecast of 7.5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast HRZN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HRZN is 6.67 USD with a low forecast of 6 USD and a high forecast of 7.5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
1 Sell
Hold
Current: 6.450
Low
6
Averages
6.67
High
7.5
Current: 6.450
Low
6
Averages
6.67
High
7.5
UBS
Doug Harter
Buy
maintain
AI Analysis
2025-11-19
Reason
UBS
Doug Harter
Price Target
AI Analysis
2025-11-19
maintain
Buy
Reason
UBS analyst Doug Harter raised the firm's price target on Horizon Technology to $6.50 from $6.25 and keeps a Buy rating on the shares.
UBS
Neutral
downgrade
$7
2025-10-14
Reason
UBS
Price Target
$7
2025-10-14
downgrade
Neutral
Reason
UBS lowered the firm's price target on Horizon Technology to $6.25 from $7 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HRZN